Archives of Clinical Infectious Diseases

Published by: Kowsar

Toxoplasma gondii Infection and Related Risk Factors among Blood Donors in Northwest Iran

Reza Bahhaj 1 , 2 , Ehsan Ahmadpour 3 , 4 , Mahmoud Mahami-Oskouei 1 , 2 , * , Esmaeil Fallah 2 , Karim Shamsasenjan 5 , 6 and Abdolrasoul Safaiyan 7
Authors Information
1 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3 Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4 Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran
5 Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
7 Department of Biostatistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2017, 12 (2); e62005
  • Published Online: April 30, 2017
  • Article Type: Research Article
  • Received: October 8, 2016
  • Revised: February 19, 2017
  • Accepted: March 4, 2017
  • DOI: 10.5812/archcid.62005

To Cite: Bahhaj R, Ahmadpour E, Mahami-Oskouei M, Fallah E, Shamsasenjan K, et al. Toxoplasma gondii Infection and Related Risk Factors among Blood Donors in Northwest Iran, Arch Clin Infect Dis. 2017 ; 12(2):e62005. doi: 10.5812/archcid.62005.

Abstract
Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005; 6(1): 41-61[DOI][PubMed]
  • 2. Ahmadpour E, Daryani A, Sharif M, Sarvi S, Aarabi M, Mizani A, et al. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2014; 8(12): 1503-10[DOI][PubMed]
  • 3. Sharif M, Daryani A, Ebrahimnejad Z, Gholami S, Ahmadpour E, Borhani S, et al. Seroprevalence of anti-Toxoplasma IgG and IgM among individuals who were referred to medical laboratories in Mazandaran province, northern Iran. J Infect Public Health. 2016; 9(1): 75-80[DOI][PubMed]
  • 4. Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, et al. Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res. 2016; 115(8): 3169-74[DOI][PubMed]
  • 5. Mahami Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, et al. The correlation between Toxoplasma gondii infection and Parkinson's disease: a case-control study. J Parasit Dis. 2016; 40(3): 872-6[DOI][PubMed]
  • 6. Menati Rashno M, Fallahi S, Kheirandish F, Bagheri S, Kayedi MH, Birjandi M. Seroprevalence of Toxoplasma gondii infection in patients with alzheimer’s disease. Arch Clin Infect Dis. 2016; 11(3)[DOI]
  • 7. Sepulveda-Arias JC, Gomez-Marin JE, Bobic B, Naranjo-Galvis CA, Djurkovic-Djakovic O. Toxoplasmosis as a travel risk. Travel Med Infect Dis. 2014; 12(6 Pt A): 592-601[DOI][PubMed]
  • 8. Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther. 2012; 10(7): 815-28[DOI][PubMed]
  • 9. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009; 49(6): 878-84[DOI][PubMed]
  • 10. Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg. 2014; 90(5): 794-9[DOI][PubMed]
  • 11. Derouin F, Pelloux H, Escmid Study Group on Clinical Parasitology . Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008; 14(12): 1089-101[DOI][PubMed]
  • 12. Elhence P, Agarwal P, Prasad KN, Chaudhary RK. Seroprevalence of Toxoplasma gondii antibodies in North Indian blood donors: implications for transfusion transmissible toxoplasmosis. Transfus Apher Sci. 2010; 43(1): 37-40[DOI][PubMed]
  • 13. Shaddel M, Mirzaii Dizgah I, Sharif F. The prevalence of toxoplasmosis in Imam Reza Hospital blood bank samples, Tehran, Iran. Transfus Apher Sci. 2014; 51(2): 181-3[DOI][PubMed]
  • 14. Hamidi F, Etemadi J, Ghabouli Mehrabani N, Mahami Oskouei M, Motavalli R, Ardalan MR. Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients. J Coast Life Med. 2015; 3(8): 621-2[DOI]
  • 15. Mahmoudvand H, Saedi Dezaki E, Soleimani S, Baneshi MR, Kheirandish F, Ezatpour B, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran. Parasite Immunol. 2015; 37(7): 362-7[DOI][PubMed]
  • 16. Chiang TY, Hsieh HH, Kuo MC, Chiu KT, Lin WC, Fan CK, et al. Seroepidemiology of Toxoplasma gondii Infection among healthy blood donors in Taiwan. PLoS One. 2012; 7(10)[DOI][PubMed]
  • 17. Alvarado-Esquivel C, Mercado-Suarez MF, Rodriguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, Nevarez-Piedra LJ, et al. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis. 2007; 7: 75[DOI][PubMed]
  • 18. Alvarado-Esquivel C, Torres-Castorena A, Liesenfeld O, Garcia-Lopez CR, Estrada-Martinez S, Sifuentes-Alvarez A, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico. J Parasitol. 2009; 95(2): 271-4[DOI][PubMed]
  • 19. Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015; 8: 292[DOI][PubMed]
  • 20. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002; 185 Suppl 1-82[DOI][PubMed]
  • 21. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002; 8(10): 634-40[PubMed]
  • 22. Arab-Mazar Z, Fallahi S, Koochaki A, Haghighi A, Seyyed Tabaei SJ. Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 7 protein for the detection of toxoplasmosis in patients with cancer. Microbiol Res. 2016; 183: 53-9[DOI][PubMed]
  • 23. Fallahi S, Mazar ZA, Ghasemian M, Haghighi A. Challenging loop-mediated isothermal amplification (LAMP) technique for molecular detection of Toxoplasma gondii. Asian Pac J Trop Med. 2015; 8(5): 366-72[DOI][PubMed]
  • 24. Prusa AR, Hayde M, Unterasinger L, Pollak A, Herkner KR, Kasper DC. Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection. Diagn Microbiol Infect Dis. 2010; 68(4): 352-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments